- Filed
- Mar 6, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 29, 2024 | 202.81M sh |
| Shares Diluted | Q2 2024 · Jan 31, 2024 | 203.9M sh |
| Shares Diluted | Q2 2024 · Jan 31, 2024 | 204.2M sh |
| Shares Diluted | Q2 2024 · Jan 31, 2023 | 207.8M sh |
| Shares Diluted | Q2 2024 · Jan 31, 2023 | 208.8M sh |
| Stock Repurchased | Q2 2024 · Jan 31, 2024 | $250M |
| Stock Repurchased | Q2 2024 · Jan 31, 2024 | $2.7B |
| Stock Repurchased | Q2 2024 · Jan 31, 2023 | $564M |
| Dividends Paid | Q2 2024 · Jan 31, 2024 | $305M |
| Dividends Paid | Q2 2024 · Jan 31, 2023 | $403M |
| Capex | Q2 2024 · Jan 31, 2024 | $192M |
| Capex | Q2 2024 · Jan 31, 2023 | $242M |
| Operating Cash Flow | Q2 2024 · Jan 31, 2024 | $863M |
| Operating Cash Flow | Q2 2024 · Jan 31, 2023 | $1.17B |
| Long Term Debt | Q2 2024 · Jan 31, 2024 | $3.6B |
| Long Term Debt | Q2 2024 · Jul 31, 2023 | $3.71B |
| Short Term Debt | Q2 2024 · Jan 31, 2024 | $150M |
| Short Term Debt | Q2 2024 · Jul 31, 2023 | $55M |
| Cash And Equivalents | Q2 2024 · Jan 31, 2024 | $639M |
| Cash And Equivalents | Q2 2024 · Jul 31, 2023 | $601M |
| Stockholders Equity | Q2 2024 · Jan 31, 2024 | $5.42B |
| Stockholders Equity | Q2 2024 · Oct 31, 2023 | $5.36B |
| Stockholders Equity | Q2 2024 · Jul 31, 2023 | $5.04B |
| Stockholders Equity | Q2 2024 · Jan 31, 2023 | $4.73B |
| Stockholders Equity | Q2 2024 · Oct 31, 2022 | $5.12B |
| Stockholders Equity | Q2 2024 · Jul 31, 2022 | $4.67B |
| Current Liabilities | Q2 2024 · Jan 31, 2024 | $4.79B |
| Current Liabilities | Q2 2024 · Jul 31, 2023 | $5.43B |
| Total Liabilities | Q2 2024 · Jan 31, 2024 | $10.27B |
| Total Liabilities | Q2 2024 · Jul 31, 2023 | $10.96B |
| Current Assets | Q2 2024 · Jan 31, 2024 | $8.62B |
| Current Assets | Q2 2024 · Jul 31, 2023 | $9.08B |
| Total Assets | Q2 2024 · Jan 31, 2024 | $15.69B |
| Total Assets | Q2 2024 · Jul 31, 2023 | $15.99B |
| Eps Diluted | Q2 2024 · Jan 31, 2024 | $1.58 |
| Eps Diluted | Q2 2024 · Jan 31, 2024 | $4.12 |
| Eps Diluted | Q2 2024 · Jan 31, 2023 | $1.80 |
| Eps Diluted | Q2 2024 · Jan 31, 2023 | $4.64 |
| Eps Basic | Q2 2024 · Jan 31, 2024 | $1.58 |
| Eps Basic | Q2 2024 · Jan 31, 2024 | $4.13 |
| Eps Basic | Q2 2024 · Jan 31, 2023 | $1.81 |
| Eps Basic | Q2 2024 · Jan 31, 2023 | $4.66 |
| Sga Expense | Q2 2024 · Jan 31, 2024 | $1.47B |
| Sga Expense | Q2 2024 · Jan 31, 2024 | $2.98B |
| Sga Expense | Q2 2024 · Jan 31, 2023 | $1.43B |
| Sga Expense | Q2 2024 · Jan 31, 2023 | $2.94B |
| Net Income | Q2 2024 · Jan 31, 2024 | $322M |
| Net Income | Q2 2024 · Jan 31, 2024 | $841M |
| Net Income | Q2 2024 · Jan 31, 2023 | $374M |
| Net Income | Q2 2024 · Jan 31, 2023 | $969M |
| Operating Income | Q2 2024 · Jan 31, 2024 | $477M |
| Operating Income | Q2 2024 · Jan 31, 2024 | $1.22B |
| Operating Income | Q2 2024 · Jan 31, 2023 | $549M |
| Operating Income | Q2 2024 · Jan 31, 2023 | $1.38B |
| Gross Profit | Q2 2024 · Jan 31, 2024 | $2.03B |
| Gross Profit | Q2 2024 · Jan 31, 2024 | $4.36B |
| Gross Profit | Q2 2024 · Jan 31, 2023 | $2.06B |
| Gross Profit | Q2 2024 · Jan 31, 2023 | $4.48B |
| Cost Of Revenue | Q2 2024 · Jan 31, 2024 | $4.64B |
| Cost Of Revenue | Q2 2024 · Jan 31, 2024 | $10.02B |
| Cost Of Revenue | Q2 2024 · Jan 31, 2023 | $4.76B |
| Cost Of Revenue | Q2 2024 · Jan 31, 2023 | $10.27B |
| Revenue | Q2 2024 · Jan 31, 2024 | $6.67B |
| Revenue | Q2 2024 · Jan 31, 2024 | $14.38B |
| Revenue | Q2 2024 · Jan 31, 2023 | $6.83B |
| Revenue | Q2 2024 · Jan 31, 2023 | $14.76B |